A new role of the early endosome in restricting NLRP3 inflammasome via mitophagy

Autophagy. 2022 Jun;18(6):1475-1477. doi: 10.1080/15548627.2022.2040314. Epub 2022 Feb 23.

Abstract

NLRP3 (NLR family pyrin domain containing 3) inflammasome is a potent mediator of inflammation due to its ability to produce the pro-inflammatory cytokines IL1B (interleukin 1 beta) and IL18 in response to numerous danger signals and pathogens. Mitophagy, a selective form of autophagy, restricts NLRP3 inflammasome activation by limiting the mitochondrial-derived danger signals. Here, we demonstrated that the adaptor protein APPL1 together with its interaction partner RAB5 in early endosomes negatively regulate NLRP3 inflammasome activation via induction of mitophagy in macrophages. Hematopoietic-deletion of Appl1 exacerbates systemic NLRP3 inflammasome activation in rodent models under obese or septic conditions. Our study identified a new regulatory network between early endosomes and mitochondria in control of NLRP3 inflammasome activation.

Keywords: APPL1; NLRP3 inflammasome; RAB5; early endosome; mitochondria; mitophagy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Autophagy
  • Endosomes / metabolism
  • Inflammasomes* / metabolism
  • Mitophagy*
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Reactive Oxygen Species / metabolism

Substances

  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Reactive Oxygen Species

Grants and funding

This work was supported by Research Grants Council, University Grants Committee (Hong Kong) [171018/15M], National Natural Science Foundation of China (NSFC) [Grant number: 91857119] and PolyU Internal Funding to Kenneth King-yip Cheng and Kelvin Ka-lok Wu.